Lobeline effects on tonic and methamphetamine-induced dopamine release

Biochemical Pharmacology

Volumn 75, Issue 6, 2008, Pages 1411-1415

  Wilhelm, Clare J ^a,b   Johnson, Robert A ^a   Eshleman, Amy J ^a,b   Janowsky, Aaron ^a,b,c  

^a PORTLAND VA MEDICAL CENTER   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Dopamine; Dopamine transporter; Lobeline; Methamphetamine; Vesicular monoamine transporter

Indexed keywords

3BETA (4 IODOPHENYL) 2BETA TROPANECARBOXYLIC ACID METHYL ESTER; DOPAMINE; DOPAMINE TRANSPORTER; LOBELINE; METHAMPHETAMINE; NOMIFENSINE; RESERPINE; UNCLASSIFIED DRUG; VESICULAR MONOAMINE TRANSPORTER 2; VESICULAR MONOAMINE TRANSPORTER 2 INHIBITOR;

ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DOPAMINE RELEASE; DRUG EFFICACY; DRUG MECHANISM; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 39749162240     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2007.11.019     Document Type: Article

References (18)

1. L.P. Dwoskin P.A. Crooks A novel mechanism of action and potential use for lobeline as a treatment for psychostimulant abuse Biochem Pharmacol 63 2002 89 98
2. L. Teng P.A. Crooks L.P. Dwoskin Lobeline displaces [3H]dihydrotetrabenazine binding and releases [3H]dopamine from rat striatal synaptic vesicles: comparison with d-amphetamine J Neurochem 71 1998 258 265
3. 3H]dopamine uptake J Pharmacol Exp Ther 280 1997 1432 1444
4. D. Sulzer T.K. Chen Y.Y. Lau H. Kristensen S. Rayport A. Ewing Amphetamine redistributes dopamine from synaptic vesicles to the cytosol and promotes reverse transport J Neurosci 15 1995 4102 4108
5. D. Sulzer M.S. Sonders N.W. Poulsen A. Galli Mechanisms of neurotransmitter release by amphetamines: a review Prog Neurobiol 75 2005 406 433
6. T. Rasmussen M.D.B. Swedberg Reinforcing effects of nicotinic compounds: intravenous self-administration in drug-naïve mice Pharmacol Biochem Behav 60 1998 567 573
7. S.B. Harrod L.P. Dwoskin T.A. Green B.J. Gehrke M.T. Bardo Lobeline does not serve as a reinforcer in rats Psychopharmacology 165 2003 397 404
8. S.B. Harrod L.P. Dwoskin P.A. Crooks J.E. Klebaur M.T. Bardo Lobeline attenuates d -methamphetamine self-administration in rats J Pharmacol Exp Ther 298 2001 172 179
9. Y. Sakurai Y. Takano Y. Kohjimoto K. Hondopamine H.O. Kamiya Enhancement of [3H]dopamine release and its [3H]metabolites in rat striatum by nicotinic drugs Brain Res 242 1982 99 106
10. + stimulation, methamphetamine and nicotinic drugs. Brain Res 279 1983 330 334
11. D.K. Miller P.A. Crooks G. Zheng V.P. Grinevich S.D. Norrholm L.P. Dwoskin Lobeline analogs with enhanced affinity and selectivity for plasmalemma and vesicular monoamine transporters J Pharmacol Exp Ther 310 2004 1035 1045
12. A.J. Eshleman R.A. Henningsen K.A. Neve A. Janowsky Release of dopamine via the human transporter Mol Pharmacol 45 1994 312 316
13. C.J. Wilhelm R.A. Johnson P.G. Lysko A.J. Eshleman A. Janowsky Effects of methamphetamine and lobeline on vesicular monoamine and dopamine transporter-mediated dopamine release in a cotransfected model system J Pharm Exp Ther 310 2004 1142 1151
14. J.W. Haycock L. Becker L. Ang Y. Furukawa O. Hornykiewicz S.J. Kish Marked disparity between age-related changes in dopamine and other presynaptic dopaminergic markers in human striatum J Neurochem 87 2003 575 585
15. S.R. Jones R.R. Gainetdinov R.W. Wightman M.G. Caron Mechanims of amphetamine action revealed in mice lacking the dopamine transporter J Neurosci 18 1998 1979 1986
16. C.J. Chantry F.J. Seidler T.A. Slotkin Non-neurogenic mechanism for reserpine-induced release of catcholamines from the adrenal medulla of neonatal rats: possible modulation by opiate receptors Neuroscience 7 1982 673 678
17. D.K. Miller P.A. Crooks L. Teng J.M. Witkin P. Munzar S.R. Goldberg Lobeline inhibits the neurochemical and behavioral effects of amphetamine J Pharmacol Exp Ther 296 2001 1023 1034
18. F.J. Vocci N.M. Appel Approaches to the development of medications for the treatment of methamphetamine dependence Addiction 102 Suppl. 1 2007 96 106